Piramal Pharma Ltd
NSE: PPLPHARMA BSE: 543635
₹237.76
+4.07 (1.74%)
Sat, 07 Nov 2026, 08:12 pm
Market Cap (in Cr)31133.58
PE Ratio0
Dividend0.06
Health Technology
Pharmaceuticals: Major
24.5KPiramal Pharma Cashflow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Deprecation and amortization | -5.86B | -6.77B | -7.41B | -8.16B |
| Accumulated depreciation, total | -15.35B | -19.49B | -23.64B | -28.09B |
| Cash from operating activities | 7.10B | 2.88B | 5.65B | 5.00B |
| Funds from operations | 10.02B | 5.83B | 7.99B | 9.88B |
| Net income (cash flow) | 3.76B | -1.86B | 178.20M | 911.30M |
| Depreciation & amortization (cash flow) | 5.86B | 6.77B | 7.41B | 7.79B |
| Depreciation/depletion | 3.56B | 4.09B | 4.38B | — |
| Amortization | 2.30B | 2.67B | 3.02B | — |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 |
| Non-cash items | -250.10M | 742.10M | -612.50M | -1.32B |
| Changes in working capital | -2.92B | -2.95B | -2.34B | -4.88B |
| Cash from investing activities | -18.94B | -14.14B | -4.56B | -5.24B |
| Capital expenditures | -8.90B | -9.65B | -7.12B | -6.64B |
| Capital expenditures - fixed assets | -8.90B | -9.65B | -7.12B | -6.64B |
| Capital expenditures - other assets | — | — | — | — |
| Cash from financing activities | 9.33B | 10.89B | 394.20M | -24.30M |
| Free cash flow | -1.80B | -6.76B | -1.47B | -1.64B |
